he Drug Discovery for Neurodegeneration course advances drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies. The course is designed to give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges. The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis. Target Audience: -Academic and industry scientists engaged in drug discovery research for neurodegenerative disease or CNS -Business development and licensing professionals -Alliance management professionals -Young investigators and graduate students